Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

Fig. 1

The change of serum lipid profile levels and ox-LDL in both groups during follow-up. The patients with ASCVD divided into two groups, the combination group who received Ezetimibe10mg/d with atorvastatin 20 mg/d(group A20E10, n = 48)and statin alone group who received atorvastatin40mg/d(group A40, n = 50).Serum levels of lipid profile were measured at baseline, week 4 and week 12 after treatment. a average TC levels,*Indicate the level of TC in group A20E10 was lower than that in group A40 significantly at week 4 and week 12 after treatment. b average LDL-C level,*Indicate the level of LDL-C in group A20E10 was lower than that in group A40 significantly at week 12 after treatment. c average TG level. d average HDL-C level. e average Non-HDL-C level. f average ox-LDL level. Notes: A20E10 indicates the patients who received Atorvastatin 20 mg qn plus Ezetimibe 10 mg qd,A40 indicates the patients who received Atorvastatin 40 mg qn

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X